Press

The government underlined Denmark’s strong tradition for protecting patient security, its important research environment, and how it has become a force when it comes to having an innovative pharmaceutical industry. The agency and its 900 employees will be forced to leave London and the UK following the Brexit vote last year. Lars Rebien Sørensen, the former head of Novo Nordisk and new special envoy tasked with helping to bring the EMA to Copenhagen, highlighted that the Danish capital had a lot going for it. “Denmark has one of the world’s leading pharmaceutical industries and we already host the headquarters of the World Health Association (WHO),” said Sørensen. (Copenhagen Post)